ARGENX SE ARGX

Latest FY: 2025 Healthcare Biotechnology
Market Price $984.46
Market Cap $60.92B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑89.9% YoY
$4.15B
3-Yr CAGR: 118.0%
Net Income ↑55.1% YoY
$1.29B
Net Margin: 31.1%
Free Cash Flow ↑2,690.0% YoY
$248.69M
FCF Yield: 0.41%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
17.6%
ROA: 14.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ARGX)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2017: Revenue YoY (+147.5%) is identical to Gross Profit YoY (+147.5%). Verify the underlying Revenue and Gross Profit values for FY 2017 and FY 2016.
  • FY 2018: Revenue YoY (-41.0%) is identical to Gross Profit YoY (-41.0%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
  • FY 2019: Revenue YoY (+224.8%) is identical to Gross Profit YoY (+224.8%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
  • FY 2020: Revenue YoY (-47.8%) is identical to Gross Profit YoY (-47.8%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
  • FY 2021: Revenue YoY (+1265.2%) is identical to Gross Profit YoY (+1265.2%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $14.7M $12.4M $-21.4M
FY 2017 $36.4M +147.5% $30.7M $-27.5M -28.6% 0.00%
FY 2018 $21.5M -41.0% $18.1M $-65.8M -139.6% 0.00% $-0.6M $-1.2M
FY 2019 $69.8M +224.8% $58.8M $-163.0M -147.5% 0.00% $-4.4M $-6.0M -402.1%
FY 2020 $36.4M -47.8% $30.7M $-526.1M -222.9% 0.00% $-2.5M $-3.4M +43.0%
FY 2021 $497.3M +1,265.2% $419.2M $-399.7M +24.0% 0.00% $15.8M $12.1M +457.4%
FY 2022 $400.7M -19.4% $371.3M $-709.6M -77.5% 0.00% $24.1M $23.3M +91.8%
FY 2023 $1,190.8M +197.2% $1,072.9M $-295.1M +58.4% 0.00% $37.5M $36.7M +57.5%
FY 2024 $2,185.9M +83.6% $1,958.6M $833.0M +382.3% 0.00% $-7.8M $-9.6M -126.2%
FY 2025 $4,151.3M +89.9% $3,700.7M $1,292.0M +55.1% 0.00% $254.9M $248.7M +2,690.0%
$

Valuation

Market Price $984.46
Market Cap $60.92B
Enterprise Value $57.43B
P/E Ratio N/A
P/B Ratio 8.32
FCF Yield 0.41%
Dividend Yield 0.00%
Shares Outstanding 61,883,306
%

Profitability & Margins

Gross Margin 89.14%
Operating Margin 25.38%
Net Margin 31.12%
Return on Equity (ROE) 17.64%
Return on Assets (ROA) 14.88%
Asset Turnover 0.48x
Revenue 3-Yr CAGR 118.00%
🛡️

Financial Health & Liquidity

Current Ratio 163.45
Cash Ratio 82.71
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $3.49B
Total Debt N/A
Book Value / Share $118.34
💧

Cash Flow Efficiency

Operating Cash Flow $254.85M
Capital Expenditures (CapEx) $6.17M
Free Cash Flow $248.69M
OCF / Revenue 6.14%
FCF / Revenue 5.99%
FCF 3-Yr CAGR 120.16%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $118.34
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $8.68B
Total Liabilities $1.36B
Stockholders' Equity $7.32B
Current Assets $6.90B
Current Liabilities $42.21M